Harri Lempiäinen and Philippe Couttet and Federico Bolognani and Arne Müller and Valérie Dubost and Rapha\"elle Luisier and Espinola Alberto Del Rio and Veronique Vitry and Elif B Unterberger and John P Thomson and Fridolin Treindl and Ute Metzger and Clemens Wrzodek and Florian Hahne and Tulipan Zollinger and Sarah Brasa and Magdalena Kalteis and Magali Marcellin and Fanny Giudicelli and Albert Braeuning and Laurent Morawiec and Natasa Zamurovic and Ulrich Längle and Nico Scheer and Dirk Schübeler and Jay Goodman and Salah-Dine Chibout and Jennifer Marlowe and Diethilde Theil and David J Heard and Olivier Grenet and Andreas Zell and Markus F Templin and Richard R Meehan and C. Roland Wolf and Clifford R Elcombe and Michael Schwarz and Pierre Moulin and Rémi Terranova and Jonathan G Moggs

Identification of Dlk1-Dio3 imprinted gene cluster non-coding RNAs as novel candidate biomarkers for liver tumor promotion.

Toxicological Sciences vol. 131 (2012), no. 2, pp. 375-386


Abstract

The molecular events during non-genotoxic carcinogenesis and their temporal order are poorly understood but thought to include long-lasting perturbations of gene expression. Here, we have investigated the temporal sequence of molecular and pathological perturbations at early stages of phenobarbital-mediated liver tumor promotion in vivo. Molecular profiling (mRNA, miRNA, DNA methylation & proteins) of mouse liver during 13 weeks of phenobarbital treatment revealed progressive increases in hepatic expression of long non-coding RNAs and microRNAs originating from the Dlk1-Dio3 imprinted gene cluster, a locus that has recently been associated with stem cell pluripotency in mice and various neoplasms in humans. Phenobarbital-induction of the Dlk1-Dio3 cluster non-coding RNA Meg3 was localised to glutamine synthetase positive hypertrophic perivenous hepatocytes suggesting a role for β-catenin signaling in the dysregulation of Dlk1-Dio3 non-coding RNAs. The carcinogenic relevance of Dlk1-Dio3 locus non-coding RNA induction was further supported by in vivo genetic dependence on Constitutive Androstane Receptor (CAR) and β-catenin pathways. Our data identify Dlk1-Dio3 non-coding RNAs as novel candidate early biomarkers for mouse liver tumor promotion and provide new opportunities for assessing the carcinogenic potential of novel compounds.


Downloads and Links

[doi] [pdf] [pdf]


BibTeX

@article{Harri2012,
  author = {Harri Lempi\"ainen and Philippe Couttet and Federico Bolognani and
	Arne M\"uller and Val\'{e}rie Dubost and Rapha\"elle Luisier and
	Espinola Alberto {Del Rio} and Veronique Vitry and Elif B Unterberger
	and John P Thomson and Fridolin Treindl and Ute Metzger and Clemens
	Wrzodek and Florian Hahne and Tulipan Zollinger and Sarah Brasa and
	Magdalena Kalteis and Magali Marcellin and Fanny Giudicelli and Albert
	Braeuning and Laurent Morawiec and Natasa Zamurovic and Ulrich L\"angle
	and Nico Scheer and Dirk Sch\"ubeler and Jay Goodman and Salah-Dine
	Chibout and Jennifer Marlowe and Diethilde Theil and David J Heard
	and Olivier Grenet and Andreas Zell and Markus F Templin and Richard
	R Meehan and {C. Roland} Wolf and Clifford R Elcombe and Michael
	Schwarz and Pierre Moulin and R\'{e}mi Terranova and Jonathan G Moggs},
  title = {{Identification of \emph{Dlk1}-\emph{Dio3} imprinted gene cluster
	non-coding RNAs as novel candidate biomarkers for liver tumor promotion}.},
  journal = {Toxicological Sciences},
  year = {2012},
  volume = {131},
  pages = {375--386},
  number = {2},
  month = oct,
  abstract = {The molecular events during non-genotoxic carcinogenesis and their
	temporal order are poorly understood but thought to include long-lasting
	perturbations of gene expression. Here, we have investigated the
	temporal sequence of molecular and pathological perturbations at
	early stages of phenobarbital-mediated liver tumor promotion in vivo.
	Molecular profiling (mRNA, miRNA, DNA methylation & proteins) of
	mouse liver during 13 weeks of phenobarbital treatment revealed progressive
	increases in hepatic expression of long non-coding RNAs and microRNAs
	originating from the Dlk1-Dio3 imprinted gene cluster, a locus that
	has recently been associated with stem cell pluripotency in mice
	and various neoplasms in humans. Phenobarbital-induction of the Dlk1-Dio3
	cluster non-coding RNA Meg3 was localised to glutamine synthetase
	positive hypertrophic perivenous hepatocytes suggesting a role for
	$\beta$-catenin signaling in the dysregulation of Dlk1-Dio3 non-coding
	RNAs. The carcinogenic relevance of Dlk1-Dio3 locus non-coding RNA
	induction was further supported by in vivo genetic dependence on
	Constitutive Androstane Receptor (CAR) and $\beta$-catenin pathways.
	Our data identify Dlk1-Dio3 non-coding RNAs as novel candidate early
	biomarkers for mouse liver tumor promotion and provide new opportunities
	for assessing the carcinogenic potential of novel compounds.},
  doi = {10.1093/toxsci/kfs303},
  eprint = {http://toxsci.oxfordjournals.org/content/131/2/375.full.pdf+html},
  institution = {Discovery and Investigative Safety, Preclinical Safety, Novartis
	Institutes for Biomedical Research, CH-4057 Basel, Switzerland.},
  keywords = {Non-genotoxic carcinogenesis, Phenobarbital, biomarker, non-coding
	RNAs, Dlk1-Dio3 Imprinted cluster, epigenetics},
  language = {eng},
  pdf = {http://toxsci.oxfordjournals.org/content/131/2/375.full.pdf},
  pii = {kfs303},
  pmid = {23091169},
  url = {http://toxsci.oxfordjournals.org/content/131/2/375.abstract}
}